Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

25 Apr 2016 07:00

RNS Number : 1437W
Biome Technologies PLC
25 April 2016
 

25 April 2016

 

 

Biome Technologies plc

("Biome", the "Company" or the "Group")

 

Trading Update

 

 

In advance of its Annual General Meeting today, Biome, a leading bioplastics and radio frequency technology business, is pleased to announce a trading update for the three months ended 31 March 2016.

 

Total Group revenues achieved for the first three months of the year were £1.1m, in line with the same quarter last year (2015: £1.1m).

 

The Group made a small profit before interest, tax, depreciation, amortisation, and share option charges in this quarter (based on unaudited management accounts).

 

The Group's cash position as at 31 March 2016 was £1.6m (31 December 2015: £1.6m) reflecting the current trading activity. Increases in capitalised development spend were offset by working capital reductions.

 

Bioplastics Division

Revenues in the Bioplastics division in Q1 2016 were £0.2m (Q1 2015: £0.5m) reflecting the timings of campaign production runs in the US single-serve coffee market. The new temperature-tolerant material underwent final customer production run trials in the quarter and revenues of this product are expected to build over the coming months.

 

Further progress has been made on the development of a biodegradable non-woven mesh. The Group also received further government funding of £0.7m in the quarter, highlighted in the 2015 full year results, to continue its medium term development work on bio-based materials.

 

Stanelco RF Technologies Division

Revenues for Q1 2016 in the RF Technologies division were £0.9m (Q1 2015: £0.6m). Good revenue levels were supported by orders for fibre optic furnaces and activity associated with the £1.5m contract to supply advanced analytical equipment to a customer in a regulated industry. Both systems for this contract are due to be delivered before the end of June 2016.

 

Outlook

Biome continues to make good progress against the strategy as set out in the Group's full year results in March 2016 and against this background the Board remains confident in the Group's outlook for the remainder of the year.

 

 

 

 

- Ends -

 

 

 

 

For further information please contact:

 

Biome Technologies plc

 

Paul Mines, Chief Executive Officer

 

Declan Brown, Group Finance Director

 

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

 

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

 

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

FTI Consulting

 

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKQDQKBKBPQB
Date   Source Headline
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement
30th Aug 20057:03 amRNSRe Agreement
5th Aug 200511:15 amRNSRe posting of circular
1st Aug 20057:01 amRNSDirector Appointment
28th Jul 20057:01 amRNSUpdate re: trials with ASDA
26th Jul 20057:00 amRNSContract Win
19th Jul 20057:00 amRNSRe Agreement
5th Jul 20057:01 amRNSRe Joint Venture
29th Jun 20057:00 amRNSInterim Results
22nd Jun 20057:00 amRNSUpdate re trials with Asda
8th Jun 20055:29 pmRNSAdditional Listing
8th Jun 200510:00 amRNSAppointment of Group MD
8th Jun 20057:50 amRNSPlacing of Ordinary Shares
6th Jun 20057:01 amRNSAcquisition
3rd Jun 20053:02 pmRNSIssue of Equity
23rd May 20057:01 amRNSRe Contract
17th May 200512:12 pmRNSAdditional Listing
10th May 20057:00 amRNSUpdate re. trials with Asda
29th Apr 20053:46 pmRNSHolding(s) in Company
25th Apr 20053:27 pmRNSDirector Shareholding
22nd Apr 20052:24 pmRNSResult of AGM
22nd Apr 200511:31 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.